INNOVATE Corp.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
(2) Subsequent Events
- Subsequent Events
Refer to Note 6. Investments for details related to the FDA approval received for MediBeacon's TGFR subsequent to year end. Refer to Note 11. Debt Obligations for details related to amendments to the Company's debt instruments subsequent to year end. Refer to Note 16. Equity and Temporary Equity for details related to R2 Technologies' issuance of a convertible note subsequent to year end.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.